Nei pazienti in terapia con insulina o sulfaniluree, il rischio di ipoglicemia aumenta per effetto di classe dei farmaci associati: ci non vieta limpiego, ma richiede riduzioni posologiche e un monitoraggio pi serrato, soprattutto durante la titolazione
Cardiovascular strain
Despite the lack of research on tirzepatide, especially in HF patients, its cardiovascular effects indicate potential benefits for this population
Understanding the underlying genetic mechanisms responsible for each type of muscular dystrophy is crucial for accurate diagnosis and targeted treatment approaches
Right now, tirzepatide is considered one of the strongest peptides available, helping people lose up to 20% of their body weight
Esposito C, Garzarella EU, Santarcangelo C, et al